Study on the Efficacy and Toxicity of Pamiparib Combined With Tamoxifen in the Treatment of Epithelial Ovarian Cancer Patients With Biochemical Recurrence During First-line PARPi Maintenance Therapy
Clinical trial NCT05669768 · UNKNOWN
Trial details
- NCT number
- NCT05669768
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2024-07-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.